Treatment Overview
High-Dose Mitomycin-C (MMC) Trabeculectomy in Korea is an enhanced filtration surgery designed for patients at high risk of trabeculectomy failure due to aggressive scarring. By applying a higher concentration of MMC—an anti-fibrotic agent—surgeons significantly reduce postoperative fibrosis, maintain filtration, and achieve long-term intraocular pressure (IOP) reduction even in complex, refractory glaucoma cases.
Korean glaucoma centers are globally recognized for their precision in MMC micro-dosing, OCT-guided tissue evaluation, and AI-assisted scarring prediction, ensuring safe and effective outcomes tailored to each patient’s healing profile.
Purpose & Benefits
Purpose
- Prevent fibrosis and closure of the filtration site in high-risk patients.
- Achieve strong, long-lasting reduction in IOP.
- Enable trabeculectomy success in eyes with aggressive wound healing tendencies.
- Delay or avoid the need for glaucoma drainage devices or more invasive surgery.
Benefits
- Superior Anti-Scarring Control: High-dose MMC provides a stronger inhibition of fibroblast activity.
- Higher Long-Term Success Rates: Effective in patients with previous surgical failures.
- Deep, Stable IOP Reduction: Ideal for severe and advanced glaucoma.
- Reduced Medication Dependence: Many patients can reduce or eliminate eye drops.
- Strong, Diffuse Bleb Formation: Improved bleb morphology and longevity.
- Effective for Secondary Glaucomas: Particularly useful in uveitic, neovascular, or steroid-induced cases.
Ideal Candidates
High-Dose MMC Trabeculectomy in Korea is ideal for:
- Patients with refractory or advanced glaucoma.
- Individuals with strong scarring tendencies, such as:
- Younger patients
- Patients of Asian or African descent
- History of keloids
- Thick Tenon’s capsule
- Patients with previous failed trabeculectomy.
- Individuals with secondary glaucoma (traumatic, neovascular, uveitic, inflammatory, steroid-induced).
- Those whose IOP cannot be controlled despite multiple medications or laser therapy.
Possible Risks & Complications
Higher MMC concentrations require advanced surgical precision. Potential risks include:
- Mild to moderate conjunctival thinning
- Hypotony (low IOP)
- Small bleb leaks
- Increased risk of bleb-related infection
- Transient inflammation
- Fragile or avascular bleb tissue
Korean surgeons significantly minimize these risks through customized MMC exposure time, protective wound-modulation techniques, and intensive postoperative monitoring.
Types of High-Dose MMC Applications in Korea
Focal High-Dose MMC Application
Applied only to areas at greatest risk of scarring.
Wide-Area High-Dose MMC Application
Used for extremely high-risk eyes with severe fibrosis tendencies.
Layered MMC Application Technique
MMC applied in multiple layers to control concentration and exposure depth.
High-Dose MMC with Implant Support
Combines MMC with collagen or gel implants for maximum filtration stability.
Combined MMC + 5-FU Protocol
Sequential anti-scarring therapy for extreme-risk glaucoma.
Surgical Techniques
AI-Based Fibrosis Prediction
Determines optimal MMC dose, placement, and exposure duration.
Conjunctival and Scleral Mapping
OCT identifies tissue thickness and scarring zones.
High-Dose MMC Sponge or Injection Application
Delivered safely using micro-dose control technology.
Scleral Flap Creation
Extended or reinforced flap improves outflow control.
Trabecular Block Excision
Establishes a controlled drainage pathway.
Peripheral Iridectomy
Prevents obstruction of the filtration opening.
Anti-Scarring Postoperative Management
May include 5-FU injections, bleb massage, or needling revision.
Treatment Process in Korea
Step 1 – Comprehensive Evaluation
Includes IOP testing, OCT imaging, angle assessment, and scarring risk analysis.
Step 2 – Customized MMC Planning
AI-supported calculations determine MMC concentration and exposure time.
Step 3 – High-Dose MMC Trabeculectomy
Performed under local anesthesia using advanced micro-precision techniques.
Step 4 – Immediate Postoperative Care
Includes steroid therapy, antibiotics, and possible 5-FU reinforcement.
Step 5 – Long-Term Monitoring
Regular OCT and biomicroscopy ensure bleb stability and filtration function.
Treatment Duration: 30–45 minutes
Setting: Hospital or surgical center
Recovery & After-Care
After-Care Guidelines
- Use prescribed eye drops consistently for several weeks.
- Avoid rubbing the eye, bending forward, or lifting heavy weights.
- Keep the eye dry; avoid pools, saunas, and contaminated environments.
- Wear protective eyewear while sleeping for the first week.
- Attend all follow-up visits for IOP checks and bleb evaluation.
Recovery Timeline
- Days 1–3: Mild redness or irritation.
- Week 1: Early bleb formation; IOP begins to decrease significantly.
- Weeks 2–4: Bleb stabilizes and becomes diffuse.
- Months 1–3: Long-term pressure stability achieved.
Results & Longevity
Expected Results
- 40–65% reduction in intraocular pressure.
- Higher success rates in high-risk fibrosis cases.
- Durable bleb morphology with strong filtration.
- Significant medication reduction in most patients.
- Better outcomes compared to standard MMC trabeculectomy in difficult cases.
Longevity
- Results typically last 10–20+ years in many patients.
- Korean anti-scarring methods dramatically extend surgical success.
- Revision or reinforcement can be performed if needed.
Why Korea Is a Top Destination
- Global leaders in anti-scarring glaucoma surgery.
- AI-guided MMC dosing ensures patient-specific precision.
- High-resolution OCT imaging enhances surgical accuracy.
- Low complication rates thanks to Korean micro-technique and postoperative care.
- Comprehensive glaucoma centers support long-term patient management.
Unique Korean Innovations
- Micro-layered high-dose MMC application for safer depth control.
- AI-enhanced fibrosis prediction models.
- MMC microdosing techniques tailored to conjunctival thickness.
- Real-time OCT bleb monitoring during postoperative care.
- Hybrid high-dose MMC + implant strategies for extreme-risk eyes.
Cost Range (Indicative Estimate)
| Procedure Type | Price (KRW) | Approx. USD | Includes |
|---|---|---|---|
| Standard High-Dose MMC Trabeculectomy | ₩4,000,000 – ₩6,500,000 | ~$3,000 – $4,900 | High-dose MMC + surgery |
| Layered or Wide-Area Application Technique | ₩5,000,000 – ₩7,500,000 | ~$3,750 – $5,600 | Extended MMC + imaging |
| High-Dose MMC + Implant-Supported Filtration | ₩6,500,000 – ₩9,000,000 | ~$4,900 – $6,750 | Implant + MMC + extended follow-up |
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul) – Experts in advanced MMC-enhanced filtration.
- Dream Eye Center (Seoul) – Specializes in high-risk anti-fibrotic trabeculectomy.
- BGN Eye Clinic (Busan & Seoul) – Leaders in MMC + implant hybrid techniques.
- Glory Seoul Eye Clinic – Renowned for precise MMC application and postoperative bleb management.
- K-Cure Vision Center (Gangnam) – Innovators in AI-based MMC dosing strategies.
If you’d like, I can also prepare:
